PTC Therapeutics | PTCT - Ordinary Share Capital



PTC Therapeutics reported $79.38M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 167.36M 167.35M Jun/2025
Alnylam Pharmaceuticals USD 130.98M 129.67M Jun/2025
Amgen USD 538M 33.04B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
BioMarin Pharmaceutical USD 192M 191.81M Jun/2025
Cytokinetics USD 119.6M 119.48M Jun/2025
Daiichi Sankyo JPY 1.85B 48.15B Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
Incyte USD 194.12M 193.93M Jun/2025
Ionis Pharmaceuticals USD 159.2M 159.04M Jun/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Novartis USD 793M 0 Dec/2024
Pfizer USD 5.68B 5.2B Jun/2025
PTC Therapeutics USD 79.38M 79.3M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sarepta Therapeutics USD 97.71M 97.7M Jun/2025
TG Therapeutics USD 158.02M 157.87M Jun/2025
Ultragenyx Pharmaceutical USD 96.35M 2.45M Jun/2025
Vertex Pharmaceuticals USD 256.3M 253.7M Jun/2025
Xencor USD 71.3M 70.58M Jun/2025